Akutagawa K, Miki S, Yamada E, Sakamoto N, et al. PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine. J Neurooncol 2025 Jun 12. doi: 10.1007/s11060-025-05102.
PMID: 40504311